Channels - Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER :: FRELIP Discovery

Similar Items: Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER

Quick Look
Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER
Quick Look
TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer
Quick Look
The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application
Quick Look
A Novel Strategy for Treating Elderly Patients with Advanced Non-Small Cell Lung Cancer: Exploring the Efficacy and Safety of Anlotinib Combined with PD-1/PD-L1 Inhibitors
Quick Look
Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression
Quick Look
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure
Quick Look
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
Quick Look
Suicide adverse events associated with zopiclone and eszopiclone: A pharmacovigilance analysis based on FAERS, JADER and CVARD
Quick Look
Heterogeneous CoO–Pd interface along with oxygen vacancies boosts the oxygen reduction reaction performance of Pd nanoparticles
Quick Look
PD-L1 expression patterns in stage IB1 cervical squamous cell carcinoma: a retrospective study on implications for tumor budding and immune microenvironment
Quick Look
Comprehensive post-marketing safety evaluation of atezolizumab: A disproportionality analysis based on individual case safety reports in the FAERS
Quick Look
Retraction: Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition
Quick Look
Combined administration of interleukin-2 and 18 with anti-PD-L1 antibody induces CCL5-positive CD8 T cells to suppress liver tumors
Quick Look
Mining the FAERS database reveals new safety signals for 120 mg denosumab in oncology practice
Quick Look
Mathematical Modeling and Control of Drone Swarm Coordination Using PD Approach
Quick Look
Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancer
Quick Look
Correction: Back to the future: The advantage of studying key events in human evolution using a new high resolution radiocarbon method
Quick Look
Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)
Quick Look
Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy using spontaneous reports: A 20-year signal detection study based on the FAERS database
Quick Look
Assessing the real-world safety of vutrisiran for transthyretin-mediated amyloidosis with polyneuropathy: Based on WHO-VigiAccess and FAERS databases
Quick Look
Correction: Targeted drug screening for autism based on Cav1.2 calcium ion channel
Quick Look
Oxidation Characteristic and Activity Evaluation of Anode Off Gas (AOG) by Pd-Pt Catalyst
Quick Look
Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Quick Look
Correction: The relationship between screen time, screen content for children aged 1–3, and the risk of ADHD in preschools